The Necessity of Guidance: Optimizing Adjuvant Therapy for Stage II/III MSI-H Gastric Cancer Through the Interplay of Evidence, Clinical Judgment, and Patient Preferences

被引:1
|
作者
Song, Geum Jong [1 ]
Choi, Yoon Young [2 ]
机构
[1] Soonchunhyang Univ, Cheonan Hosp, Coll Med, Dept Surg, Cheonan, South Korea
[2] Soonchunhyang Univ, Bucheon Hosp, Coll Med, Dept Surg, 170 Jomaru Ro, Bucheon 14584, South Korea
关键词
D O I
10.5230/jgc.2024.24.e26
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:243 / 245
页数:3
相关论文
共 2 条
  • [1] Reply: Comment on The Necessity of Guidance: Optimizing Adjuvant Therapy for Stage II/III MSI-H Gastric Cancer Through the Interplay of Evidence, Clinical Judgment, and Patient Preferences
    Kim, In-Ho
    Choi, Wonyoung
    Han, Hye Sook
    JOURNAL OF GASTRIC CANCER, 2024, 24 (04) : 353 - 355
  • [2] PACE: A phase III trial of CAPOX versus anti-PD-1 inhibitor as adjuvant therapy for patients with dMMR/MSI-H stage III colon cancer
    Hou, Zhenlin
    Jiang, Wu
    Tang, Jinghua
    Xiao, Binyi
    Li, Yuan
    Li, Dandan
    Zhang, Xiaoshi
    Pan, Zhi-Zhong
    Ding, Peirong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)